RT @SABOURETCardio
Long-term Safety and Efficacy of Achieving Very Low Levels of #LDL : A Prespecified Analysis of the IMPROVE-IT Trial. For those who underestimate CV benefits of #ezetimibe and of low #LDL #safety https://jamanetwork.com/journals/jamacardiology/fullarticle/2611949

RT @SABOURETCardio
Efficacy and Safety of #Alirocumab 300 mg Every 4 Weeks in Individuals With #T2D. Efficient and well tolerated 1/month. Associated with fixed #LLT combinations HI #statins and #ezetimibe #lipids https://academic.oup.com/jcem/article-abstract/104/11/5253/5510497

RT @SABOURETCardio
Do you speak #lipids ? #CLEAROutcomes is online. A new validated option for #Statins intolerance. Obviously better in fixed combination with #Ezetimibe. Proven efficacy on #MACE. Expected and confirmed benefits according to magnitude of decrease/time exposure

RT @SABOURETCardio
#Ezetimibe